View Sessions

Friday, February 7th, 2020

7:15 AM- 7:45 AM

Registration, Breakfast & Exhibits

7:45 AM- 8:00 AM

Opening Remarks
Parta Hatamizadeh, MD, MPH | University of Florida | Course Director

Session I: Pulmonary Hypertension, The Heart and The Kidney

8:00 AM- 9:00 AM

Pulmonary Hypertension: The 2020 Overview
Mardi Gomberg-Maitland, MD, MSc | George Washington University

9:00 AM- 9:30 AM

Pulmonary Hypertension in Chronic Kidney Disease
Mark Sarnak, MD, MS | Tufts University

9:40 AM- 10:00 AM

Panel Discussion

10:00 AM- 10:30 AM

Break & Exhibits

Session II: Systemic Hypertension Review and Update

10:30 AM- 11:30 AM

Latest Advances in Hypertension
George Bakris, MD | University of Chicago

11:30 AM – 12:30 PM

Specific Aspects and Subtleties of Hypertension and Blood Pressure Management in Patients with Cardiovascular Diseases
Suzanne Oparil, MD | University of Alabama at Birmingham (UAB)

12:30 PM- 1:30 PM

Lunch & Exhibits

Session III: Dyslipidemia, Cardiovascular System and Kidney

1:30 PM- 2:30 PM

Contemporary Approach to Lipid Management in Cardiovascular Patients
Karol Watson, MD, PhD | UCLA David Geffen School of Medicine

2:30PM – 3:10 PM

Evidence Based Approach to Lipids and Dyslipidemia in Patients with Chronic Kidney Disease
Mark Sarnak, MD, MS | Tufts University

3:10PM – 3:30 PM

Panel Discussion

Saturday, February 8, 2020

7:15 AM- 8:00 AM

Registration, Breakfast & Exhibits

Session IV: Diabetes Mellitus: Kidney and Cardiovascular System

8:00 AM- 8:50 AM

The 2020 Outlook of Diabetes and Diabetic Nephropathy from the Nephrology Standpoint
George Bakris, MD | University of Chicago

8:50 AM- 9:40 AM

State of the Art Approach to Diabetes and Glycemic Control from the Cardiology Standpoint
Karol Watson, MD, PhD | UCLA David Geffen School of Medicine

9:40 AM- 10:00 AM

Evidence Based Approach to Glycemic Control with Newly Emerged Therapies

10:00 AM- 10:30 AM

Break & Exhibits

Session V: Uric Acid and Hyperuricemia: Kidney and Cardiovascular System

10:30 AM- 11:20 AM

Overview and Update on Uric Acid and Hyperuricemia
N. Lawrence Edwards, MD | University of Florida

11:20 AM – 12:10 PM

Hyperuricemia in Kidney Diseases and Cardiovascular Diseases
Richard Johnson, MD | University of Colorado

12:10 pM – 12:30 PM

Panel Discussion: Asymptomatic Hyperuricemia: To Treat or not to Treat?

12:30 PM- 1:30 PM

Lunch & Exhibits

Session VI: Amyloidosis, Deposition Diseases, and Other Connections Between Kidney and Cardiovascular                Diseases

1:30 PM- 2:10 PM

Cardiac Amyloidosis: What is New?
Rodney H. Falk, MD | Harvard University

2:10 PM- 2:50 PM

Renal Amyloidosis and Deposition Diseases
Mark Segal, MD, PhD | University of Florida

2:50 PM- 3:30 PM

Clinical Importance of The Connection Between Renal Glomerular Diseases and Cardiovascular Diseases
Parta Hatamizadeh, MD, MPH | University of Florida

Sunday, February 9th, 2020

7:15 AM- 8:00 AM

Registration, Breakfast & Exhibits

Session VII: Inflammation, Immune System, The Heart and The Kidney

8:00 AM- 9:00 AM

Updates on Myocarditis and Cardiac Inflammation: What Does a Clinician Need to Know?
Leslie T. Cooper, JR, MD | Mayo Clinic

9:00 AM- 10:00 AM

Autoimmunity, Inflammation and Kidney Diseases in Clinical Practice
Laura Mariani, MD, MS | University of Michigan

10:00 AM- 10:30 AM

Break & Exhibits

Session VIII: Abstract presentation and General Question and Answer

10:30AM – 10:50AM

Portal vein flow guided decongestion in cardio-renal syndrome: A POCUS Series
Eduardo Argaiz, MD | Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirám

10:50AM – 11:10AM

Parity and Cardiovascular Disease Risk in Women with Chronic Kidney Disease
Sandra Dumanski, MD | University of Calgary

11:10AM – 11:30AM

Outcome in hospitalized patients treated with PRN anti-HTN medications: A single center experience
Gajapathiraju Chamarthi, MD | University of Florida

11:30AM – 11:50AM

Open-Source Software for Measuring Vascular Compliance from DICOM Ultrasound Data
Timothy Morgan, PhD | University of Michigan

11:50AM – 12:30PM

Question and Answer
Leslie Cooper, MD; Mark Segal, MD, PhD, Laura Mariani, MD, MS; Parta Hatamizadeh, MD, MPH

12:30 PM

Closing Remarks

Parta Hatamizadeh, MD, MPH | University of Florida | Course Director